DaVita Inc. (DVA)

US — Healthcare Sector
Peers: ENSG  ALGN  UHS  ATR  BIO  CHE  MOH  RVMD  BMRN  HSIC 

Automate Your Wheel Strategy on DVA

With Tiblio's Option Bot, you can configure your own wheel strategy including DVA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol DVA
  • Rev/Share 173.3053
  • Book/Share 20.4499
  • PB -26.44
  • Debt/Equity -34.6705
  • CurrentRatio 1.3935
  • ROIC 0.1094

 

  • MktCap 9201335000.0
  • FreeCF/Share 16.9651
  • PFCF 7.1418
  • PE 11.6865
  • Debt/Assets 0.7326
  • DivYield 0
  • ROE -25.9516

 

  • Rating B
  • Score 3
  • Recommendation Neutral
  • P/E Score 3
  • DCF Score 5
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Why DaVita Inc Stock Is Plummeting Today
DVA
Published: February 14, 2025 by: The Motley Fool
Sentiment: Negative

Shares of DaVita Inc (DVA -11.09%) are trading lower on Friday. The company's stock lost 11.1% as of market close but lost as much as 15.2% earlier in the day.

Read More
image for news Why DaVita Inc Stock Is Plummeting Today
DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.
DVA
Published: February 14, 2025 by: Market Watch
Sentiment: Negative

DaVita shares were tumbling 13.5% Friday to lead S&P 500 decliners, after Warren Buffett's Berkshire Hathaway pared its stake in the provider of kidney dialysis.

Read More
image for news DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.
Here's why Warren Buffett dumped $31 million worth of this stock
DVA
Published: February 14, 2025 by: Finbold
Sentiment: Negative

Warren Buffett, the ‘Oracle of Omaha', managed to attain a roughly $142 billion net worth by consistently outperforming the markets. The Berkshire Hathaway (NYSE: BRK.B) chief executive officer (CEO) and chairman did so by utilizing a careful, level-headed approach to investing.

Read More
image for news Here's why Warren Buffett dumped $31 million worth of this stock
DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript
DVA
Published: February 13, 2025 by: Seeking Alpha
Sentiment: Neutral

DaVita Inc. (NYSE:DVA ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Participants Joanna Gajuk - Bank of America AJ Rice - UBS Pito Chickering - Deutsche Bank Justin Lake - Wolfe Research Andrew Mok - Barclays Ryan Langston - TD Cowen Operator Good evening. My name is Michelle, and I will be your conference facilitator today.

Read More
image for news DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript
Berkshire sells some DaVita shares, cuts stake to 45%
BRK-A, BRK-B, DVA
Published: February 13, 2025 by: Reuters
Sentiment: Negative

Berkshire Hathaway said on Thursday night it sold 203,091 shares of DaVita , reducing its stake in the kidney dialysis services provider to about 35.89 million shares, a 45% stake worth nearly $6.4 billion.

Read More
image for news Berkshire sells some DaVita shares, cuts stake to 45%
DVA Q4 Estimates Unchanged Before Earnings: How to Play the Stock?
DVA
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive

Continued strength in RPT is likely to have boosted DaVita's top line in the fourth quarter despite supply challenges weighing on its performance.

Read More
image for news DVA Q4 Estimates Unchanged Before Earnings: How to Play the Stock?

About DaVita Inc. (DVA)

  • IPO Date 1995-10-31
  • Website https://www.davita.com
  • Industry Medical - Care Facilities
  • CEO Javier J. Rodriguez
  • Employees 76000

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.